Cumberland Pharmaceuticals Inc. (CPIX) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and welcome to the Cumberland Pharmaceuticals first quarter 2025 financial report and company update. This call is being recorded at the company's request and will be archived on its website for one year from today's date. I would now like to turn the call over to Molly Agus, Account Supervisor at the Dalton Agency, who handles Cumberland's communications. Molly, please proceed. Hello everyone and thank you for joining us today. This afternoon, Cumberland issued a press release announcing its first quarter financial results. The release also provided an operational update, including key developments during the quarter. The release, which includes the related financial tables, can be found on the company's website at www.cumberlandpharma.com. Management will share an overview of those financial results during today's call. They'll also provide an overall company update, including a discussion of Cumberland's brands, pipeline, and partners. Participating in today's call are AJ Kazemi, Cumberland's Chief Executive Officer, along with Todd Anthony, Vice President, Organizational Development, and John Hamm, Chief Financial Officer. Please keep in mind that their discussions may include some forward-looking statements, as defined in the Private Securities Reform Act. Those statements reflect the company's current views and expectations concerning future events. It may involve risks as well as uncertainties. There are many factors that could affect Cumberland's future results, including natural disasters, economic downturns, public health epidemics, international conflicts, trade restrictions, and others that are beyond the company's control. Those issues are described under the caption risk factors. in Cumberland's Form 10-K and any additional updates filed ...